Intentar ORO - Gratis

THE Beautiful AND THE Damned

Newsweek US

|

May 09, 2025

How GLP-1 drugs like MOUNJARO and OZEMPIC are redefining the debate about size, weight loss and PRIVILEGE

- by JESUS MESA

THE Beautiful AND THE Damned

SAMHITA MUKHOPADHYAY WASN'T expecting shame to come from a photo. The longtime feminist writer and former Teen Vogue editor had just moderated a panel at a media conference. She was dressed in a skirt and printed top she felt good in—until she saw a candid image someone had posted online. “It was devastating,” she told Newsweek. Mukhopadhyay took Mounjaro, an antidiabetic medication also used for weight loss, and saw dramatic results—losing 15 percent of her body weight over 18 months. She was feeling physically better, sleeping more soundly and even considering a wardrobe overhaul. But the cost of the drug forced her to stop. “I knew better,” she said. “As a feminist writer and committed proponent of body positivity, I'd spent years trying to love my body at any size. And yet, here I was, agonizing over a picture of myself.

That contradiction, she said, was the real heartbreak—not just for her, but for the women who long-embraced the body positivity messaging themselves. “Taking something for weight loss made me feel like I was being vain, that I didn’t have the willpower to lose weight, eat better or exercise,” she said. “It felt like a violation of an unspoken norm.”

Hollywood's Open Secret

IN RECENT YEARS, MOUNJARO AND SIMILAR GLP-1 DRUGS like Wegovy, Ozempic and Zepbound have redefined how America thinks—and talks—about weight. What began as a diabetes treatment has become a billion-dollar industry fueled by off-label use, celebrity whispers and red-carpet transformations.

As the 2025 Hollywood awards season kicked off with the Golden Globes in January, so too did another round of jokes, speculation and sponsorships linking the industry to the use of GLP-1 medications for weight loss by A-list celebrities. Comedian Nikki Glaser, host of the Globes, dove right in at the start of her opening monologue: “Good evening, and welcome to the 82nd Golden Globes—Ozempic’s biggest night,” she began.

MÁS HISTORIAS DE Newsweek US

Newsweek US

Newsweek US

Jesse Williams

FOR HOTEL COSTIERA, JESSE WILLIAMS WAS DRAWN TO MAKING “SOME- thing that’s global.” The new Prime Video series stars Williams as Daniel De Luca, a former Marine who returns home to Italy to work at a hotel, only to find himself tasked with finding the missing daughter of the hotel’s owner. While he has “no complaints” filming in Positano paradise, “I tried to stay rela- tively disciplined, but I ate a lot of pasta and bread.” Of the character, he related to his duality. “I don’t really say I’m half anything,” he notes. “That has to have found itself stewing in something Daniel De Luca is dealing with.” The series represents a new phase for Williams, taking creative control as a producer. “It certainly feels good...to bet on you in the same way you're trying to bet on your- self.” After leaving his role on Grey’s Anatomy, his first move was a deliberate challenge, Broadway, and now this, raising the stakes by creating an original show. “Like, it’s really trying to forge something new in a space.” But ultimately, it’s all about the process. “I love the collaboration that exists in our business.”

time to read

1 min

October 10, 2025

Newsweek US

Newsweek US

Elvira

ELVIRA FIRMLY BELIEVES HALLOWEEN requires spooky snacks, and she's here to provide some inspiration with Elvira's Cookbook from Hell: Sexy, Spooky Soirées and Celebrations for Every Occasion.

time to read

2 mins

October 10, 2025

Newsweek US

Newsweek US

Freeing the Bird

Elon Musk said he purchased Twitter to champion free speech, but this exclusive excerpt says it was more about advancing a personal, right-leaning agenda

time to read

12 mins

October 10, 2025

Newsweek US

Newsweek US

'This Has Changed the Region Forever'

Qatari spokesperson Majed al-Ansari tells Newsweek of Gulf leaders' plans to warn President Donald Trump of a \"new threat perception\" following Israel's strikes in Doha

time to read

11 mins

October 10, 2025

Newsweek US

Newsweek US

STREETS AHEAD

CHINA IS IN THE DRIVER'S SEAT WHEN IT NATIONAL SECURITY IMPLICATIONS FOR THE U.S. COMES TO EV TECHNOLOGY-WHICH POSES HUGE

time to read

12 mins

October 10, 2025

Newsweek US

Newsweek US

Beyond Skin Deep

After walking away from her namesake brand, Bobbi Brown is proving reinvention can be as powerful as invention

time to read

6 mins

October 10, 2025

Newsweek US

Newsweek US

Food for Thought

Americans are increasing their protein intake, but at what cost to the sustainable food movement?

time to read

4 mins

October 10, 2025

Newsweek US

Britain's MAGA Moment

Former Prime Minister Liz Truss' hopes for a right-wing overhaul

time to read

3 mins

October 10, 2025

Newsweek US

Newsweek US

Poles Apart

Egypt and Saudi Arabia's clash of governing philosophies is accelerating schisms across the Middle East and North Africa

time to read

3 mins

October 10, 2025

Newsweek US

Newsweek US

AMERICA'S MOST Admired WORKPLACES 2026

WHEN PEOPLE CONSIDER THEIR DREAM JOB, they often put companies they admire at the top of the list.

time to read

4 mins

October 03, 2025

Listen

Translate

Share

-
+

Change font size